111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.75%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-71.54%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-93.45%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-93.45%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-7.86%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
5.56%
Positive EPS growth while JHX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.56%
Positive diluted EPS growth while JHX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-11.52%
Share reduction while JHX is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-11.51%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
277.81%
10Y revenue/share CAGR above 1.5x JHX's 30.24%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
84.68%
5Y revenue/share CAGR above 1.5x JHX's 30.24%. David Dodd would look for consistent product or market expansions fueling outperformance.
80.61%
3Y revenue/share CAGR above 1.5x JHX's 30.24%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
169.86%
Net income/share CAGR 1.25-1.5x JHX's 126.45%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
141.24%
5Y net income/share CAGR 1.25-1.5x JHX's 126.45%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
184.47%
3Y net income/share CAGR 1.25-1.5x JHX's 126.45%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
134.52%
5Y equity/share CAGR above 1.5x JHX's 43.77%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.46%
3Y equity/share CAGR 1.25-1.5x JHX's 43.77%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.